MGX Metagenomi Therapeutics, Inc.

Fundamentals / CIK 0001785279 / USD

Metagenomi Therapeutics, Inc. reported $25.21M in revenue and a net loss of $94.19M for the fiscal year ended December 31, 2025 (down 51.8% year over year), with a -396.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MGX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$60.82M$30.41M$0-$86.60MFY 2023 Revenue: $44.76MFY 2023 Net Income: -$68.25M2023FY 2024 Revenue: $52.30MFY 2024 Net Income: -$78.06M2024FY 2025 Revenue: $25.21MFY 2025 Net Income: -$87.87M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $25.21M $52.30M $44.76M
Research & Development $94.43M $109.2M $94.40M
Total Operating Expenses $121.2M $141.2M $123.2M
Operating Income -$96.01M -$88.90M -$78.49M
EBITDA -$90.70M -$83.49M -$74.28M
Interest Income $9.47M $14.72M $15.47M
Income Before Tax -$87.93M -$83.57M -$60.23M
Income Tax Expense -$58K -$5.51M $8.03M
Net Income -$87.87M -$78.06M -$68.25M
Basic EPS -$2.36 -$2.36 -$20.05
Diluted EPS -$2.36 -$2.36 -$20.05
Basic Shares Outstanding 37.3M 33.0M 3.4M
Diluted Shares Outstanding 37.3M 33.0M 3.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $2.18M -- $1.25M $3.91M $8.66M $8.51M $4.13M $9.61M
Research & Development $17.53M $22.51M $19.30M $21.50M $25.28M $22.51M $25.14M $23.16M
Total Operating Expenses $24.41M $28.52M $25.84M $28.28M $31.50M $29.50M $31.95M $30.24M
Operating Income -$22.23M -$28.77M -$24.59M -$24.37M -$22.84M -$20.99M -$27.82M -$20.62M
EBITDA -$20.97M -$27.51M -$23.31M -$23.07M -$21.52M -$19.65M -$26.46M -$19.16M
Interest Income $1.05M $1.26M $1.54M $1.88M $2.21M $2.48M $2.89M $3.20M
Income Before Tax -$21.13M -$27.48M -$23.05M -$22.49M -$20.63M -$19.86M -$24.94M -$24.61M
Income Tax Expense $0 $0 $10K $34K -$234K $44K $98K -$1.21M
Net Income -$21.13M -$27.48M -$23.06M -$22.53M -$20.39M -$19.91M -$25.04M -$23.40M
Basic EPS -$0.56 -$0.73 -$0.61 -- -$0.55 -$0.54 -$0.68 --
Diluted EPS -$0.56 -$0.73 -$0.61 -- -$0.55 -$0.54 -$0.68 --
Basic Shares Outstanding 37.8M 37.7M 37.6M -- 37.3M 37.2M 37.0M --
Diluted Shares Outstanding 37.8M 37.7M 37.6M -- 37.3M 37.2M 37.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $41.72M $27.39M $140.6M
Short-Term Investments $119.1M $220.9M $130.6M
Cash & Short-Term Investments $160.8M $248.3M $271.2M
Accounts Receivable, Net $305K $1.10M $2.45M
Total Current Assets $165.5M $258.0M $278.3M
Property, Plant & Equipment, Net $12.29M $17.74M $21.54M
Long-Term Investments $2.15M $3.45M $10.68M
Other Non-Current Assets $836K $287K $5.49M
Total Non-Current Assets $55.56M $66.64M $86.57M
Total Assets $221.1M $324.6M $364.8M
Accounts Payable $1.49M $533K $1.79M
Deferred Revenue (Current) $8.70M $22.76M $48.07M
Total Current Liabilities $22.93M $37.31M $68.86M
Deferred Revenue (Non-Current) $2.99M $10.24M $30.93M
Other Non-Current Liabilities $1.95M $2.01M $5.08M
Total Non-Current Liabilities $39.57M $52.43M $80.81M
Total Liabilities $62.51M $89.74M $149.7M
Total Debt (incl. Leases) $40.66M $45.78M $48.23M
Common Stock $4.0K $4.0K $0
Retained Earnings -$310.9M -$223.0M -$144.9M
Accumulated Other Comp. Income $260K $709K -$97K
Total Stockholders' Equity $158.6M $234.9M -$135.6M
Total Equity $158.6M $234.9M -$135.6M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $36.11M $39.03M $25.31M $41.72M $32.77M $26.85M $29.20M $27.39M
Short-Term Investments $65.57M $81.64M $114.9M $119.1M $151.3M $178.1M $196.8M $220.9M
Cash & Short-Term Investments $101.7M $120.7M $140.2M $160.8M $184.1M $205.0M $226.0M $248.3M
Accounts Receivable, Net $0 $0 $0 $305K $960K $900K $900K $1.10M
Total Current Assets $110.9M $124.5M $144.6M $165.5M $189.8M $211.7M $233.2M $258.0M
Property, Plant & Equipment, Net $8.62M $9.90M $11.16M $12.29M $13.89M $15.11M $16.52M $17.74M
Long-Term Investments $2.15M $2.15M $2.15M $2.15M $2.15M $2.15M $3.45M $3.45M
Other Non-Current Assets $988K $1.02M $927K $836K $809K $805K $781K $287K
Total Non-Current Assets $46.53M $49.23M $52.40M $55.56M $58.12M $60.60M $64.67M $66.64M
Total Assets $157.4M $173.7M $197.0M $221.1M $247.9M $272.3M $297.9M $324.6M
Accounts Payable $773K $2.60M $2.40M $1.49M $1.22M $2.89M $2.67M $533K
Deferred Revenue (Current) $9.01M $11.20M $9.31M $8.70M $12.90M $18.94M $25.50M $22.76M
Total Current Liabilities $32.34M $27.63M $22.50M $22.93M $29.58M $33.27M $39.89M $37.31M
Deferred Revenue (Non-Current) $0 $0 $1.64M $2.99M $1.90M $3.55M $4.37M $10.24M
Other Non-Current Liabilities $2.02M $2.02M $1.95M $1.95M $1.92M $2.15M $2.11M $2.01M
Total Non-Current Liabilities $31.86M $33.50M $36.67M $39.57M $39.91M $43.19M $45.31M $52.43M
Total Liabilities $64.20M $61.13M $59.17M $62.51M $69.49M $76.45M $85.21M $89.74M
Total Debt (incl. Leases) $36.21M $37.72M $39.19M $40.66M $41.66M $42.99M $44.44M $45.78M
Common Stock $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K
Retained Earnings -$382.5M -$361.4M -$333.9M -$310.9M -$288.3M -$267.9M -$248.0M -$223.0M
Accumulated Other Comp. Income -$159K -$122K -$44K $260K $371K $372K $621K $709K
Total Stockholders' Equity $93.19M $112.6M $137.8M $158.6M $178.4M $195.8M $212.7M $234.9M
Total Equity $93.19M $112.6M $137.8M $158.6M $178.4M $195.8M $212.7M $234.9M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$87.87M -$78.06M -$68.25M
Depreciation & Amortization $5.32M $5.41M $4.21M
Stock-Based Compensation $11.85M $16.20M $6.92M
Change in Receivables $952K $1.19M -$2.45M
Change in Payables $1.05M -$1.11M -$84K
Operating Cash Flow -$88.89M -$109.1M -$91.41M
Capital Expenditure -$574K -$3.11M -$9.81M
Free Cash Flow -$89.47M -$112.2M -$101.2M
Purchases of Investments -$66.41M -$306.1M -$208.1M
Investing Cash Flow $103.5M -$88.16M $45.73M
Financing Cash Flow -$356K $84.01M $1.01M
Net Change in Cash $14.28M -$113.2M -$44.66M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$21.13M -$27.48M -$23.06M -$22.53M -$20.39M -$19.91M -$25.04M -$23.40M
Depreciation & Amortization $1.25M $1.26M $1.27M $1.30M $1.32M $1.33M $1.36M $1.46M
Stock-Based Compensation $1.78M $2.27M $2.55M $2.69M $3.01M $3.22M $2.93M $3.41M
Change in Receivables $0 $0 $305K $655K -$87K $139K $245K -$668K
Change in Payables -$1.83M $319K $795K $346K -$1.58M $74K $2.21M -$2.57M
Operating Cash Flow -$19.08M -$19.51M -$21.18M -$23.55M -$21.25M -$21.25M -$22.84M -$26.28M
Capital Expenditure $21K -$125K -$25K -$85K -$74K -$127K -$288K -$334K
Free Cash Flow -$19.06M -$19.64M -$21.20M -$23.63M -$21.33M -$21.38M -$23.13M -$26.61M
Purchases of Investments -$13.66M -$3.91M -$36.75M -$19.55M -$6.06M -$18.51M -$22.29M -$12.34M
Investing Cash Flow $16.16M $33.17M $3.99M $32.37M $27.36M $19.07M $24.73M $28.55M
Financing Cash Flow $0 $67K -$27K $74K -$187K -$166K -$77K $0
Net Change in Cash -$2.92M $13.72M -$17.22M $8.89M $5.92M -$2.35M $1.81M $2.27M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Operating Margin -380.9% -170.0% -175.4%
Net Profit Margin -348.5% -149.3% -152.5%
Return on Equity (ROE) -55.4% -33.2% --
Return on Assets (ROA) -39.7% -24.0% -18.7%
Current Ratio 7.22x 6.91x 4.04x
Quick Ratio 7.03x 6.68x 3.97x
Debt to Equity 0.26x 0.19x --
Revenue Growth (YoY) -51.8% +16.8% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -415.5% -380.9% -298.5% -271.9% -193.7% -170.0%
Net Profit Margin -- -- -384.6% -348.5% -287.1% -258.0% -172.2% -149.3%
Return on Equity (ROE) -101.1% -83.0% -62.3% -55.4% -49.7% -44.5% -36.7% -33.2%
Return on Assets (ROA) -59.8% -53.8% -43.6% -39.7% -35.8% -32.0% -26.2% -24.0%
Current Ratio 3.43x 4.50x 6.43x 7.22x 6.42x 6.36x 5.85x 6.91x
Quick Ratio 3.14x 4.37x 6.23x 7.03x 6.26x 6.19x 5.69x 6.68x
Debt to Equity 0.39x 0.34x 0.28x 0.26x 0.23x 0.22x 0.21x 0.19x
Revenue Growth (YoY) -74.8% -- -69.8% -59.3% -24.8% -57.5% -63.0% -22.5%
Source: SEC EDGAR CompanyFacts (CIK 0001785279) · from March 31, 2023 Data through September 30, 2026 · synced Nov 21, 2026, 05:02 UTC · Open in terminal